Promacta 50 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F19BU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,752
Award facts
- Contract value 100% obligated
- $50,752.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This $50,752.38 firm fixed-price delivery order is scheduled for completion by December 29, 2025, with performance based in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded to AmerisourceBergen, a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive experience fulfilling military and veteran healthcare pharmaceutical requirements across multiple therapeutic domains. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles. This particular delivery order for Promacta, an immunosuppressant medication used to treat thrombocytopenia, reflects the company's ongoing role as a primary pharmaceutical supplier within the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F19BU?
SPE2DR26F19BU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F19BU worth?
The government has obligated $50,752 on SPE2DR26F19BU.
Is contract SPE2DR26F19BU an order under another contract?
Yes. SPE2DR26F19BU is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F19BU competed?
The extent of competition for SPE2DR26F19BU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award